The primary objective of the proposal is to support Mayo Clinic's participation in the Children's Cancer Study Group. This will allow continuing support for the cooperative group activites of the Pediatric Oncology Group at Mayo Clinic and its satellites in Des Moines, Iowa; Fargo, North Dakota; and Duluth, Minnesota. The ultimate goal of the proposal is to develop methods for long-term control and cure in a wide variety of malignant diseases in children while evaluating and minimizing the adverse short-term and long-term effects of treatment. Clinical research in pediatric cancer demands a coordinated team effort involving surgeons, therapeutic radiologists, pathologists, pediatric oncologists, immunologists, histochemists, pharamcologists and radiologists. Solid tumor treatment protocols are becoming increasing more complex and accurate pretreatment staging and standardized operative, radiotherapuetic and chemotherapeutic procedures are essential. Since pediatric surgeons, pediatric urologists, orthopedic oncologic surgeons and diagnostic radiologists play a major role in diagnosis, staging and surgical therapy of solid tumor patients and also participate actively in postoperative evaluation, reporting and data analysis, their formal involvement in this program is critical for maintaining the highest level of clinical and laboratory research within the Children's Cancer Study Group. In addition, psychosocial evaluation and support for the patient and family is considered essential to the successful outcome of this type of clinical research and can also provide a basis for the development of clinical research studies for evaluating the psychosocial impact of cancer on children and their families.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10CA028882-05
Application #
3557014
Study Section
Cancer Clinical Investigation Review Committee (CCI)
Project Start
1981-01-01
Project End
1988-11-30
Budget Start
1984-12-01
Budget End
1985-11-30
Support Year
5
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Seitzman, Robin L; Glover, Dorie A; Meadows, Anna T et al. (2004) Self-concept in adult survivors of childhood acute lymphoblastic leukemia: a cooperative Children's Cancer Group and National Institutes of Health study. Pediatr Blood Cancer 42:230-40
Shamberger, Robert C; LaQuaglia, Michael P; Gebhardt, Mark C et al. (2003) Ewing sarcoma/primitive neuroectodermal tumor of the chest wall: impact of initial versus delayed resection on tumor margins, survival, and use of radiation therapy. Ann Surg 238:563-7; discussion 567-8
Casillas, Jacqueline N; Woods, William G; Hunger, Stephen P et al. (2003) Prognostic implications of t(10;11) translocations in childhood acute myelogenous leukemia: a report from the Children's Cancer Group. J Pediatr Hematol Oncol 25:594-600
Davies, Stella M; Bhatia, Smita; Ross, Julie A et al. (2002) Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood 100:67-71
Wells, Robert J; Reid, Joel M; Ames, Matthew M et al. (2002) Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942. J Pediatr Hematol Oncol 24:89-93
Lange, Beverly J; Bostrom, Bruce C; Cherlow, Joel M et al. (2002) Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99:825-33
Ou, Shu Xiao; Han, Dehui; Severson, Richard K et al. (2002) Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States). Cancer Causes Control 13:15-25
Cairo, M S; Krailo, M D; Morse, M et al. (2002) Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report. Leukemia 16:594-600
Wells, R J; Arthur, D C; Srivastava, A et al. (2002) Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 16:601-7
Adamson, P C; Widemann, B C; Reaman, G H et al. (2001) A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study. Clin Cancer Res 7:3034-9

Showing the most recent 10 out of 22 publications